# A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

> **NCT04634604** · PHASE3 · TERMINATED · sponsor: **Jaeb Center for Health Research** · enrollment: 16 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Bevacizumab
- **PROCEDURE:** Laser

## Key facts

- **NCT ID:** NCT04634604
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-27
- **Primary completion:** 2023-08-14
- **Final completion:** 2023-08-14
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Lack of feasibility to recruit.
- **Last updated:** 2024-08-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04634604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04634604, "A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04634604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*